GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
Questions & Answers with Drs. Doebele and Shaw; Moderated by Craig Uthe
Acquired Resistance Forum Video #10: Online advocate and ROS1 patient ...
Acquired Resistance Forum Video #10: Online advocate and ROS1 patient "Craig In PA" Uthe leads a Q&A with speakers from videos #8 and #9 at the Acquired Resistance in Lung Cancer Patient Forum.
-
HD
Current and Emerging Approaches to Acquired Resistance for ALK/ROS1
Acquired Resistance Forum Video #9: Dr. Alice Shaw of Massachusetts ...
Acquired Resistance Forum Video #9: Dr. Alice Shaw of Massachusetts General Hospital detailed for patients the so-called "next generation" ALK/ROS1 inhibitors, both those commercially available and those still in development.
-
HD
Mechanisms of ALK Resistance & Implications for Treatment
Acquired Resistance Forum Video #8: Dr. Robert Doebele of the ...
Acquired Resistance Forum Video #8: Dr. Robert Doebele of the University of Colorado Cancer Center spoke to ALK and ROS1 patients about how and why their cancers become resistant to treatment and what options are available.
-
HD
Questions & Answers with Drs. Blumenthal and Pennell; Moderated by Dr. West
Acquired Resistance Forum Video #7: Speakers from videos #5 and ...
Acquired Resistance Forum Video #7: Speakers from videos #5 and #6 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.
-
HD
Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations
Acquired Resistance Forum Video #6: Dr. Nate Pennell of the ...
Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.
-
HD
Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era
Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the ...
Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.
-
HD
Questions & Answers with Drs. Riely, Weiss and Sequist; Moderated by Dr. West
Acquired Resistance Forum Video #4: The first three speakers at ...
Acquired Resistance Forum Video #4: The first three speakers at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.
-
HD
Repeat Biopsies & the Potential Value of Biologically-Informed Acquired Resistance Therapy
Acquired Resistance Forum Video #3: Dr. Lecia Sequist of Massachusetts ...
Acquired Resistance Forum Video #3: Dr. Lecia Sequist of Massachusetts General Hospital detailed why doctors started doing repeat biopsies for patients receiving targeted therapies and how they help patients and doctors determine next steps in treatment.
-
HD
Life After 1st Line Targeted Therapy: What Next?
Acquired Resistance Forum Video #2: Dr. Jared Weiss of the ...
Acquired Resistance Forum Video #2: Dr. Jared Weiss of the University of North Carolina addressed the Acquired Resistance in Lung Cancer Patient Forum with information on what patients' options are when their ALK, ROS1 or EGFR lung cancer progresses....
-
HD
What is Acquired Resistance and How Does it Occur?
Acquired Resistance Forum Video #1: Dr. Gregory J. Riely of ...
Acquired Resistance Forum Video #1: Dr. Gregory J. Riely of Memoral Sloan Kettering Cancer Center opened the Acquired Resistance in Lung Cancer Patient Forum with a basic introduction of how ALK, ROS1 and EGFR lung cancers become resistant to...
